{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:00:14Z","timestamp":1772110814315,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11060-026-05433-6","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:02:55Z","timestamp":1769101375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individualized prediction of brain metastasis risk in patients with breast cancer"],"prefix":"10.1007","volume":"176","author":[{"given":"Gino","family":"Cioffi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Waite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ancha","family":"Baranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill S.","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"5433_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and Trends\u2013An update. Cancer Epidemiol Biomarkers Prev 25:16\u201327","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5433_CR2","unstructured":"Cancer Facts and Figs (2025). American Cancer Society, Atlanta, 2025"},{"key":"5433_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559\u20131564","journal-title":"Science"},{"key":"5433_CR4","doi-asserted-by":"crossref","unstructured":"Park M et al (2022) Breast cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci 23","DOI":"10.3390\/ijms23126806"},{"key":"5433_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","volume":"149","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology. Handb Clin Neurol 149:27\u201342","journal-title":"Handb Clin Neurol"},{"key":"5433_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","volume":"31","author":"P Sacks","year":"2020","unstructured":"Sacks P, Rahman M (2020) Epidemiology of brain metastases. Neurosurg Clin N Am 31:481\u2013488","journal-title":"Neurosurg Clin N Am"},{"key":"5433_CR7","doi-asserted-by":"crossref","unstructured":"Yuzhalin AE, Yu D (2020) Brain metastasis organotropism. Cold Spring Harb Perspect Med 10","DOI":"10.1101\/cshperspect.a037242"},{"key":"5433_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","volume":"20","author":"A Boire","year":"2020","unstructured":"Boire A, Brastianos PK, Garzia L, Valiente M (2020) Brain metastasis. Nat Rev Cancer 20:4\u201311","journal-title":"Nat Rev Cancer"},{"key":"5433_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/ijms14011383","volume":"14","author":"I Wilhelm","year":"2013","unstructured":"Wilhelm I, Molnar J, Fazakas C, Hasko J, Krizbai IA (2013) Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci 14:1383\u20131411","journal-title":"Int J Mol Sci"},{"key":"5433_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jamaoncol.2018.0813","volume":"4","author":"DN Cagney","year":"2018","unstructured":"Cagney DN et al (2018) Implications of screening for brain metastases in patients with breast cancer and Non-Small cell lung cancer. JAMA Oncol 4:1001\u20131003","journal-title":"JAMA Oncol"},{"key":"5433_CR11","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/S1470-2045(22)00201-7","volume":"23","author":"J Knisely","year":"2022","unstructured":"Knisely J (2022) Screening for breast cancer brain metastases. Lancet Oncol 23:e200","journal-title":"Lancet Oncol"},{"key":"5433_CR12","first-page":"vdab009","volume":"3","author":"TQ Cao","year":"2021","unstructured":"Cao TQ, Dixit K, Santa-Maria C, Kumthekar P (2021) Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: A large single-institutional analysis with potential screening implications. Neurooncol Adv 3:vdab009","journal-title":"Neurooncol Adv"},{"key":"5433_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/annonc\/mdl064","volume":"17","author":"BC Pestalozzi","year":"2006","unstructured":"Pestalozzi BC et al (2006) Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the international breast cancer study group (IBCSG). Ann Oncol 17:935\u2013944","journal-title":"Ann Oncol"},{"key":"5433_CR14","doi-asserted-by":"crossref","unstructured":"Nguyen TT et al (2023) Genomics of breast cancer brain metastases: a meta-analysis and therapeutic implications. Cancers (Basel) 15","DOI":"10.3390\/cancers15061728"},{"key":"5433_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: A review. JAMA 321:288\u2013300","journal-title":"JAMA"},{"key":"5433_CR16","doi-asserted-by":"publisher","first-page":"104269","DOI":"10.1016\/j.critrevonc.2024.104269","volume":"195","author":"D Xu","year":"2024","unstructured":"Xu D et al (2024) Why does HER2-positive breast cancer metastasize to the brain and what can we do about it? Crit Rev Oncol Hematol 195:104269","journal-title":"Crit Rev Oncol Hematol"},{"key":"5433_CR17","doi-asserted-by":"crossref","unstructured":"Bryan S, Witzel I, Borgmann K (2021) & Oliveira-Ferrer, L. Molecular mechanisms associated with brain metastases in HER2-Positive and triple negative breast cancers. Cancers (Basel) 13","DOI":"10.3390\/cancers13164137"},{"key":"5433_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.18632\/oncotarget.27453","volume":"11","author":"L Koniali","year":"2020","unstructured":"Koniali L et al (2020) Risk factors for breast cancer brain metastases: a systematic review. Oncotarget 11:650\u2013669","journal-title":"Oncotarget"},{"key":"5433_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/bjc.2011.464","volume":"106","author":"C Lo Nigro","year":"2012","unstructured":"Lo Nigro C et al (2012) High frequency of complex TP53 mutations in CNS metastases from breast cancer. Br J Cancer 106:397\u2013404","journal-title":"Br J Cancer"},{"key":"5433_CR20","first-page":"vdz007","volume":"1","author":"H Gittleman","year":"2019","unstructured":"Gittleman H et al (2019) An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival. Neurooncol Adv 1:vdz007","journal-title":"Neurooncol Adv"},{"key":"5433_CR21","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than Meets the eye. Lancet Oncol 16:e173\u2013180","journal-title":"Lancet Oncol"},{"key":"5433_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12876-024-03331-7","volume":"24","author":"B Huang","year":"2024","unstructured":"Huang B et al (2024) Development and validation of a nomogram based on Lasso-Logistic regression for predicting splenomegaly secondary to acute pancreatitis. BMC Gastroenterol 24:281","journal-title":"BMC Gastroenterol"},{"key":"5433_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"APG Consortium","year":"2017","unstructured":"Consortium APG, AACR Project GENIE (2017) Powering precision medicine through an international consortium. Cancer Discov 7:818\u2013831","journal-title":"Cancer Discov"},{"key":"5433_CR24","first-page":"e2100105","volume":"6","author":"JA Lavery","year":"2022","unstructured":"Lavery JA et al (2022) A scalable quality assurance process for curating oncology electronic health records: the project GENIE biopharma collaborative approach. JCO Clin Cancer Inf 6:e2100105","journal-title":"JCO Clin Cancer Inf"},{"key":"5433_CR25","unstructured":"Project AACR GENIE 16.0-public data guide. (AACR)"},{"key":"5433_CR26","doi-asserted-by":"crossref","unstructured":"Lavery JA et al (2023) A data processing pipeline for the AACR project GENIE biopharma collaborative data with the GenieBPC R package. Bioinformatics 39","DOI":"10.1093\/bioinformatics\/btac796"},{"key":"5433_CR27","unstructured":"Whiting K, Curry M, Fuchs H, Martin A, Arora A gnomeR: Wrangle and analyze IMPACT and TCGA mutation data"},{"key":"5433_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/2767-9764.CRC-23-0409","volume":"4","author":"E Sanz-Garcia","year":"2024","unstructured":"Sanz-Garcia E et al (2024) Genomic characterization and clinical outcomes of patients with peritoneal metastases from the AACR GENIE biopharma collaborative colorectal cancer registry. Cancer Res Commun 4:475\u2013486","journal-title":"Cancer Res Commun"},{"key":"5433_CR29","unstructured":"Friedman J et al (2023) CRAN,. glmnet: Lasso and Elastic-Net Regularized Generalized Linear Models, version 4.1-8"},{"key":"5433_CR30","unstructured":"Therneau TM, Lumley T, Elizabeth A, Cynthia C (2024) survival: Survival AnalysisCRAN"},{"key":"5433_CR31","unstructured":"Therneau T, Crowson C, Atkinson E (2024) Multi-state models and competing risks"},{"key":"5433_CR32","unstructured":"Gerds TA et al (2023) risk Regression: Risk regression models and prediction scores for survival analysis with competing risks"},{"key":"5433_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/atm.2018.07.38","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang Z et al (2018) Overview of model validation for survival regression model with competing risks using melanoma study data. Ann Transl Med 6:325","journal-title":"Ann Transl Med"},{"key":"5433_CR34","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1002\/sim.6152","volume":"33","author":"TA Gerds","year":"2014","unstructured":"Gerds TA, Andersen PK, Kattan MW (2014) Calibration plots for risk prediction models in the presence of competing risks. Stat Med 33:3191\u20133203","journal-title":"Stat Med"},{"key":"5433_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/bimj.200810443","volume":"50","author":"TA Gerds","year":"2008","unstructured":"Gerds TA, Cai T, Schumacher M (2008) The performance of risk prediction models. Biom J 50:457\u2013479","journal-title":"Biom J"},{"key":"5433_CR36","unstructured":"Harrell FE (2024) rms: Regression modeling strategies"},{"key":"5433_CR37","unstructured":"Zhicheng D, Hao Y, nomogramEx (2017) Extract equations from a nomogram"},{"key":"5433_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri F et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol 21:901\u2013910","journal-title":"Neuro Oncol"},{"key":"5433_CR39","doi-asserted-by":"publisher","first-page":"1115291","DOI":"10.3389\/fimmu.2023.1115291","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer. Front Immunol 14:1115291","journal-title":"Front Immunol"},{"key":"5433_CR40","doi-asserted-by":"publisher","first-page":"714639","DOI":"10.3389\/fgene.2021.714639","volume":"12","author":"T Huang","year":"2021","unstructured":"Huang T, Yan T, Chen G, Zhang C (2021) Development and validation of a gene Mutation-Associated nomogram for hepatocellular carcinoma patients from four countries. Front Genet 12:714639","journal-title":"Front Genet"},{"key":"5433_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41413-023-00260-1","volume":"11","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang H, Yue X, Li X (2023) Bone serves as a transfer station for secondary dissemination of breast cancer. Bone Res 11:21","journal-title":"Bone Res"},{"key":"5433_CR42","doi-asserted-by":"crossref","unstructured":"Muscarella AM, Aguirre S, Hao X, Waldvogel SM, Zhang XH (2021) Exploiting bone niches: progression of disseminated tumor cells to metastasis. J Clin Invest 131","DOI":"10.1172\/JCI143764"},{"key":"5433_CR43","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459:1005\u20131009","journal-title":"Nature"},{"key":"5433_CR44","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1158\/1078-0432.CCR-17-3351","volume":"24","author":"S Kabraji","year":"2018","unstructured":"Kabraji S et al (2018) Drug resistance in HER2-Positive breast cancer brain metastases: blame the barrier or the brain? Clin Cancer Res 24:1795\u20131804","journal-title":"Clin Cancer Res"},{"key":"5433_CR45","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1158\/1078-0432.CCR-13-0790","volume":"19","author":"NU Lin","year":"2013","unstructured":"Lin NU, Amiri-Kordestani L, Palmieri D, Liewehr DJ, Steeg (2013) P.S. CNS metastases in breast cancer: old challenge, new frontiers. Clin Cancer Res 19:6404\u20136418","journal-title":"Clin Cancer Res"},{"key":"5433_CR46","doi-asserted-by":"crossref","unstructured":"Cheng XA (2024) Comprehensive review of HER2 in cancer biology and therapeutics. Genes (Basel) 15","DOI":"10.20944\/preprints202406.0515.v1"},{"key":"5433_CR47","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1038\/onc.2015.489","volume":"35","author":"S Ingthorsson","year":"2016","unstructured":"Ingthorsson S et al (2016) HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR. Oncogene 35:4244\u20134255","journal-title":"Oncogene"},{"key":"5433_CR48","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","volume":"21","author":"E Laughner","year":"2001","unstructured":"Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995\u20134004","journal-title":"Mol Cell Biol"},{"key":"5433_CR49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1186\/s12885-021-08708-5","volume":"21","author":"MD Hackshaw","year":"2021","unstructured":"Hackshaw MD et al (2021) Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review. BMC Cancer 21:967","journal-title":"BMC Cancer"},{"key":"5433_CR50","doi-asserted-by":"crossref","unstructured":"Tommasi C et al (2024) Hormone Receptor-Positive\/HER2-Positive breast cancer: hormone therapy and anti-HER2 treatment: an update on treatment strategies. J Clin Med 13","DOI":"10.3390\/jcm13071873"},{"key":"5433_CR51","doi-asserted-by":"crossref","unstructured":"Voskarides K, Giannopoulou N (2023) The Role of TP53 in adaptation and Evolution. Cells 12","DOI":"10.3390\/cells12030512"},{"key":"5433_CR52","first-page":"34","volume":"16","author":"J Huszno","year":"2018","unstructured":"Huszno J, Grzybowska E (2018) TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer. Oncol Lett 16:34\u201340","journal-title":"Oncol Lett"},{"key":"5433_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/2159-8290.CD-13-0136","volume":"4","author":"E Powell","year":"2014","unstructured":"Powell E, Piwnica-Worms D (2014) Piwnica-Worms, H. Contribution of p53 to metastasis. Cancer Discov 4:405\u2013414","journal-title":"Cancer Discov"},{"key":"5433_CR54","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s10585-013-9594-5","volume":"30","author":"AM Minisini","year":"2013","unstructured":"Minisini AM et al (2013) Risk factors and survival outcomes in patients with brain metastases from breast cancer. Clin Exp Metastasis 30:951\u2013956","journal-title":"Clin Exp Metastasis"},{"key":"5433_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13058-016-0710-8","volume":"18","author":"M Wang","year":"2016","unstructured":"Wang M et al (2016) Determining breast cancer histological grade from RNA-sequencing data. Breast Cancer Res 18:48","journal-title":"Breast Cancer Res"},{"key":"5433_CR56","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.18632\/oncotarget.2848","volume":"6","author":"M Schwaederle","year":"2015","unstructured":"Schwaederle M et al (2015) Cyclin alterations in diverse cancers: outcome and co-amplification network. Oncotarget 6:3033\u20133042","journal-title":"Oncotarget"},{"key":"5433_CR57","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1200\/JCO.2009.24.6314","volume":"28","author":"O Graesslin","year":"2010","unstructured":"Graesslin O et al (2010) Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 28:2032\u20132037","journal-title":"J Clin Oncol"},{"key":"5433_CR58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejca.2016.10.019","volume":"72","author":"L Genre","year":"2017","unstructured":"Genre L et al (2017) External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis. Eur J Cancer 72:200\u2013209","journal-title":"Eur J Cancer"},{"key":"5433_CR59","doi-asserted-by":"publisher","first-page":"853","DOI":"10.21037\/atm-21-1808","volume":"9","author":"MS Sun","year":"2021","unstructured":"Sun MS et al (2021) A nomogram for predicting brain metastasis in patients with de Novo stage IV breast cancer. Ann Transl Med 9:853","journal-title":"Ann Transl Med"},{"key":"5433_CR60","doi-asserted-by":"crossref","unstructured":"Phillips KA, Douglas MP, Wordsworth S, Buchanan J, Marshall DA (2021) Availability and funding of clinical genomic sequencing globally. BMJ Glob Health 6","DOI":"10.1136\/bmjgh-2020-004415"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05433-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:02:45Z","timestamp":1772107365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05433-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5433"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05433-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AACR Project GENIE requires that each participating center share data in a manner consistent with patient consent and center-specific Institutional Review Board (IRB) policies. These policies consist of one of the following: IRB-approved patient-consent to sharing of de-identified data, captured at time of molecular testing; IRB waivers and; and IRB approvals of GENIE-specific research proposals. Additionally, all data has been de-identified via the HIPAA Safe Harbor Method.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\/Human Ethics Declaration\/Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}